Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice
Bone and soft tissue sarcomas (STSs) represent a group of heterogeneous rare malignant tumors of mesenchymal origin, with a poor prognosis. Due to their low incidence, only a few studies have been reported addressing circulating tumor cells (CTCs) in sarcoma, despite the well-documented relevance fo...
Main Authors: | Chiara Agnoletto, Chiara Caruso, Cecilia Garofalo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/9/2189 |
Similar Items
-
Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application
by: Chiara Agnoletto, et al.
Published: (2023-03-01) -
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
by: Chiara Agnoletto, et al.
Published: (2019-04-01) -
Mitochondria dysfunction in circulating tumor cells
by: Chiara Agnoletto, et al.
Published: (2022-08-01) -
Detection of circulating tumor-derived material in peripheral blood of pediatric sarcoma patients: A systematic review
by: Eva Kristine Ruud Kjær, et al.
Published: (2023-08-01) -
Effective Circulating Tumor Cell Isolation Using Epithelial and Mesenchymal Markers in Prostate and Pancreatic Cancer Patients
by: Jiwon Cha, et al.
Published: (2023-05-01)